[Antifungal drug].
Yamaguchi
Hideyo
H
Teikyo University Institute of Medical Mycology.
D000666:Amphotericin B; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents / Q000737:chemistry / Q000145:classification / Q000493:pharmacokinetics / Q000494:pharmacology; D001393:Azoles; D000077336:Caspofungin; D015195:Drug Design; D025141:Drug Resistance, Fungal; D054714:Echinocandins; D015725:Fluconazole; D005472:Fluorouracil; D005658:Fungi / Q000187:drug effects; D006801:Humans; D017964:Itraconazole; D055666:Lipopeptides; D008074:Lipoproteins; D000077551:Micafungin; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology; D009894:Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology; D010455:Peptides; D010456:Peptides, Cyclic; D011090:Polyenes; D011743:Pyrimidines
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D001393:Azoles; D054714:Echinocandins; D055666:Lipopeptides; D008074:Lipoproteins; D010455:Peptides; D010456:Peptides, Cyclic; D011090:Polyenes; D011743:Pyrimidines; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D000077336:Caspofungin; D000077551:Micafungin; D005472:Fluorouracil